200 related articles for article (PubMed ID: 26951157)
1. In vitro susceptibility of methicillin-resistant and methicillin-susceptible strains of Staphylococcus aureus to two different cold atmospheric plasma sources.
Napp M; Daeschlein G; von Podewils S; Hinz P; Emmert S; Haase H; Spitzmueller R; Gümbel D; Kasch R; Jünger M
Infection; 2016 Aug; 44(4):531-7. PubMed ID: 26951157
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
[TBL] [Abstract][Full Text] [Related]
3. Reversion of methicillin-resistant Staphylococcus aureus skin infections to methicillin-susceptible isolates.
Patel AB; Hill E; Simpson EL; Hanifin JM
JAMA Dermatol; 2013 Oct; 149(10):1167-71. PubMed ID: 23945667
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].
Aydeniz Ozansoy F; Cevahir N; Kaleli İ
Mikrobiyol Bul; 2015 Jan; 49(1):1-14. PubMed ID: 25706726
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
Candel FJ; Morales G; Picazo JJ
Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
Chang VS; Dhaliwal DK; Raju L; Kowalski RP
Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and genotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) from different sources in China.
Chao G; Zhang X; Zhang X; Huang Y; Xu L; Zhou L; Yang W; Jiang Y; Xue F; Wu Y
Foodborne Pathog Dis; 2013 Mar; 10(3):214-21. PubMed ID: 23405883
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus strains isolated from outpatients with skin and soft tissue infections in Wuhan, China.
Liu X; Liang J; Jiang Y; Wang B; Yuan H; Zhang L; Zhou Y; Xu H; Zhou W
Pathog Dis; 2016 Jun; 74(4):ftw026. PubMed ID: 27060098
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.
Davis SL; Perri MB; Donabedian SM; Manierski C; Singh A; Vager D; Haque NZ; Speirs K; Muder RR; Robinson-Dunn B; Hayden MK; Zervos MJ
J Clin Microbiol; 2007 Jun; 45(6):1705-11. PubMed ID: 17392441
[TBL] [Abstract][Full Text] [Related]
10. Detection of staphylococcal cassette chromosome mec-associated DNA segments in multiresistant methicillin-susceptible Staphylococcus aureus (MSSA) and identification of Staphylococcus epidermidis ccrAB4 in both methicillin-resistant S. aureus and MSSA.
Shore AC; Rossney AS; O'Connell B; Herra CM; Sullivan DJ; Humphreys H; Coleman DC
Antimicrob Agents Chemother; 2008 Dec; 52(12):4407-19. PubMed ID: 18852274
[TBL] [Abstract][Full Text] [Related]
11. Rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) using the KeyPath MRSA/MSSA blood culture test and the BacT/ALERT system in a pediatric population.
Sullivan KV; Turner NN; Roundtree SS; McGowan KL
Arch Pathol Lab Med; 2013 Aug; 137(8):1103-5. PubMed ID: 23899068
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China.
Wu D; Wang Q; Yang Y; Geng W; Wang Q; Yu S; Yao K; Yuan L; Shen X
Diagn Microbiol Infect Dis; 2010 May; 67(1):1-8. PubMed ID: 20227225
[TBL] [Abstract][Full Text] [Related]
13. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.
Filice GA; Nyman JA; Lexau C; Lees CH; Bockstedt LA; Como-Sabetti K; Lesher LJ; Lynfield R
Infect Control Hosp Epidemiol; 2010 Apr; 31(4):365-73. PubMed ID: 20184420
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa.
Shittu AO; Lin J
BMC Infect Dis; 2006 Jul; 6():125. PubMed ID: 16875502
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus methicillin resistance detected by HPLC-MS/MS targeted metabolic profiling.
Schelli K; Rutowski J; Roubidoux J; Zhu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1047():124-130. PubMed ID: 27316783
[TBL] [Abstract][Full Text] [Related]
17. Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies.
Hu Y; Coates AR
J Antimicrob Chemother; 2013 Feb; 68(2):374-84. PubMed ID: 23042813
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
Sader HS; Farrell DJ; Flamm RK; Jones RN
Surg Infect (Larchmt); 2016 Aug; 17(4):443-7. PubMed ID: 26990170
[TBL] [Abstract][Full Text] [Related]
19. Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals.
Vandendriessche S; Kadlec K; Schwarz S; Denis O
J Antimicrob Chemother; 2011 Nov; 66(11):2455-9. PubMed ID: 21868413
[TBL] [Abstract][Full Text] [Related]
20. Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains.
Flamm RK; Rhomberg PR; Kaplan N; Jones RN; Farrell DJ
Antimicrob Agents Chemother; 2015 May; 59(5):2583-7. PubMed ID: 25691627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
